ANTICHOLINERGIC TOXICITY

Clinical trials for ANTICHOLINERGIC TOXICITY explained in plain language.

Never miss a new study

Get alerted when new ANTICHOLINERGIC TOXICITY trials appear

Sign up with your email to follow new studies for ANTICHOLINERGIC TOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New hope for poisoning patients: rivastigmine may stop delirium relapse

Disease control Recruiting now

This study tests whether rivastigmine, a longer-acting drug, can prevent the return of delirium in people poisoned by substances that block muscarinic receptors. After initial control with physostigmine, 42 participants aged 10 and older will receive either rivastigmine or a plac…

Matched conditions: ANTICHOLINERGIC TOXICITY

Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control

Last updated May 06, 2026 16:02 UTC

ANTICHOLINERGIC TOXICITY

Get alerted when new ANTICHOLINERGIC TOXICITY trials appear

New hope for poisoning patients: rivastigmine may stop delirium relapse